Clinical Trials in Dixon, United States
Locations / Dixon, United States
Delta Trials lists 63 clinical trials conducted in Dixon, United States, making it a notable site of clinical research activity. These trials addressing 505 medical conditions, reflecting the scope and diversity of clinical research in this location. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Dixon research landscape.
63
Total Trials
505
Conditions
0
Terminated since 2020
Browse by condition (505 total)
- Stage iiib lung cancer ajcc v8 5 trialsAll Stage iiib lung cancer ajcc v8 trials
- Recurrent ovarian carcinoma 5 trialsAll Recurrent ovarian carcinoma trials
- Stage iiia lung cancer ajcc v8 4 trialsAll Stage iiia lung cancer ajcc v8 trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- Metastatic malignant solid neoplasm 3 trialsAll Metastatic malignant solid neoplasm trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- Advanced malignant solid neoplasm 3 trialsAll Advanced malignant solid neoplasm trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- Stage iv bladder cancer ajcc v8 3 trialsAll Stage iv bladder cancer ajcc v8 trials
- Stage iv renal cell cancer ajcc v8 3 trialsAll Stage iv renal cell cancer ajcc v8 trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- All Recurrent primary peritoneal carcinoma trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- All Clinical stage iii esophageal adenocarcinoma ajcc v8 trials
- Stage iv pancreatic cancer ajcc v8 2 trialsAll Stage iv pancreatic cancer ajcc v8 trials
- All Metastatic lung non-squamous non-small cell carcinoma trials
- All Recurrent fallopian tube clear cell adenocarcinoma trials
- All Recurrent primary peritoneal clear cell adenocarcinoma trials